Fig. 1. Adverse event reporting of no flow in leukocyte reduction filters (A) and the medical device adverse event reporting process in Soonchunhyang university Bucheon hospital (SCHBC) (B).

Korean J Blood Transfus 2022;33:161-70 https://doi.org/10.17945/kjbt.2022.33.3.161

© 2022 Korean J Blood Transfus